Benelux Morning Notes

Ahold Delhaize: Walmart 3Q24/25 results. IBA: Rhodotron contract to equip a sterilization facility in Mexico. NEPI Rockcastle: Sound operational momentum. UCB: Final approval for Bimzelx in the United States

Morning Notes : ARGX BB, GIMB BB, IBAB BB, UCB BB, CTPNV NA

: ARGX BB, GIMB BB, IBAB BB, UCB BB, CTPNV NA

UCB FIRST LOOK: FDA gives 5/5 with Bimzelx' new approval in HS

UCB has received a 5th nod for Bimzelx as hidradenitis suppurativa joins the fray of approved indications. We see an important role for Bimzelx in this emerging disease space with clear potential to become standard of care over time given its clear outperformance over Novartis' Cosentyx in the clinic. We reiterate our € 173 TP and Accumulate rating.

ODDO BHF Small & MIDCAP MORNING NEWS - 11/19/2024

...

ODDO BHF Small & MIDCAP MORNING NEWS - 19/11/2024

...

ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 11/19/2024

...

ODDO BHF SECURITIES MORNING NEWS – COMMENTAIRES DETAILLES 19/11/2024

...

ODDO : Swiss watch exports for October: overall negative growth confir...

>October exports down -2.2%, luxury subsegment up 1.7% - Overall exports showing a low single-digit decline for October (YTD score now at -2.6%) cannot be perceived as a real improvement, coming after a low double-digit fall in September (-12.1%) as the number of working days was higher y-o-y last month. The luxury category has remained a visible outperformer, up 1.7%, while the three other lower-end categories have continued to suffer markedly with y-o-y falls for Oc...

ODDO : Swiss watch exports for October: overall negative growth confir...

>October exports down -2.2%, luxury subsegment up 1.7% - Overall exports showing a low single-digit decline for October (YTD score now at -2.6%) cannot be perceived as a real improvement, coming after a low double-digit fall in September (-12.1%) as the number of working days was higher y-o-y last month. The luxury category has remained a visible outperformer, up 1.7%, while the three other lower-end categories have continued to suffer markedly with y-o-y falls for Oc...

UCB FIRST LOOK: First takes on dapimap's Ph3 results in SLE

UCB shared first insights into the Phase 3 data on dapimap in SLE, which appear generally favourable with a 14.6% BICLA benefit after 48 weeks vs. SoC. The data also shows a steroid tapering effect and reduction in flares, while suggesting possible outperformance vs. current market leader Benlysta (GSK). Dapimap is co-developed with Biogen and will be continued in a second Ph3 study. We reiterate our € 173 TP and Accumulate rating.

Morning Notes : GREEN BB, SEQUA BB, UCB BB, AZE BB, ONWD BB

: GREEN BB, SEQUA BB, UCB BB, AZE BB, ONWD BB

ODDO BHF Small & MIDCAP MORNING NEWS - 18/11/2024

Comme prévu, les actions américaines ont salué la victoire de Donald Trump tandis que les bourses européennes accusaient le coup, également lestées deux jours plus tard par une nouvelle déception sur le plan de relance chinois. Nos stratégies sectorielles et paniers de valeurs Trump (long ou short) ont fonctionné, avec quelques exceptions qui peuvent être des opportunités d’investissement, à l’instar de Total Energies ou Repsol. En Europe, nous conservons notre opinion Sous-pondérer s...

ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 11/18/2024

As expected, US equities welcomed Donald Trump's victory, while European stock markets reacted negatively, also weighed down two days later by a further disappointment on China's stimulus plan. Our sector strategies and baskets of Trump stocks (long or short) have paid off, with a few exceptions that may provide investment opportunities, like Total Energies or Repsol. In Europe, we are maintaining our Underweight recommendation on the Basic Resources, Chemicals, Luxury Goods and Autom...

ODDO BHF Small & MIDCAP MORNING NEWS - 11/18/2024

As expected, US equities welcomed Donald Trump's victory, while European stock markets reacted negatively, also weighed down two days later by a further disappointment on China's stimulus plan. Our sector strategies and baskets of Trump stocks (long or short) have paid off, with a few exceptions that may provide investment opportunities, like Total Energies or Repsol. In Europe, we are maintaining our Underweight recommendation on the Basic Resources, Chemicals, Luxury Goods and Autom...

ODDO BHF SECURITIES MORNING NEWS – COMMENTAIRES DETAILLES 18/11/2024

Comme prévu, les actions américaines ont salué la victoire de Donald Trump tandis que les bourses européennes accusaient le coup, également lestées deux jours plus tard par une nouvelle déception sur le plan de relance chinois. Nos stratégies sectorielles et paniers de valeurs Trump (long ou short) ont fonctionné, avec quelques exceptions qui peuvent être des opportunités d’investissement, à l’instar de Total Energies ou Repsol. En Europe, nous conservons notre opinion Sous-pondérer s...

ODDO : Monday review – Luxury sector

>Topic of the week: margin risk quantified - Growth momentum is definitely what makes luxury stocks tick. Alas, the near-term growth outlook for the industry remains hard to decipher: the normalisation in the West is well advanced but the reacceleration might look slow going for a while, at the same time China’s demand has abruptly stopped, is poised to recover but remains hostage of overall macro conditions. It is no longer a secret by now that the sector’s growth fo...

ODDO : Monday review – Luxury sector

>Topic of the week: margin risk quantified - Growth momentum is definitely what makes luxury stocks tick. Alas, the near-term growth outlook for the industry remains hard to decipher: the normalisation in the West is well advanced but the reacceleration might look slow going for a while, at the same time China’s demand has abruptly stopped, is poised to recover but remains hostage of overall macro conditions. It is no longer a secret by now that the sector’s growth fo...

The Capital Goods Data Miner – November 2024